Testing Status of Gum Guggul Extract M050066
CASRN: GUMGUGGULEXT
Short-Term Toxicity
- 13 weeks (Gavage)
(C20605)
Completed
- TOX-99
Toxicology Studies of A Gum Guggul Extract Formulation Administered by Gavage to Sprague Dawley (Hsd:Sprague Dawley SD) Rats and B6C3F1/N Mice - Rats: Harlan Sprague-Dawley; Mice: B6C3F1
- Dose: Rats: 0, 62.5, 125, 250, 500, or 1000; Mice: 0, 15.5, 31, 62.5, 125, or 250, or mg/kg.
- TOX-99
Special Studies
- Absorption Distribution Metabolism Excretion (in-vitro)
(S0939)
Completed
- Human (Cell Lines) [HU]
- Dose: (in-vitro) 0, 0.3, 1, 10 µM [HU].
Genetic Toxicology
- Micronucleus
(G05066)
Completed
- Rats: Harlan Sprague-Dawley
- Male Negative
- Female Negative
- Micronucleus
(G05066B)
Completed
- Mice: B6C3F1
- Male Negative
- Female Negative
Organ Systems Toxicity
- 28 days Immunotoxicity (Gavage)
(IMM20701)
Completed
- Female Mice: B6C3F1
- Dose: 0, 31.25, 62.5, 125, 250, OR 500 MG/KG/DAY.